Chapter
Chapter 2: Pharmacokinetics
Clinical Pharmacokinetics
Chapter 3: Autonomic Pharmacology
Chapter 4: Drug Interactions
Mechanisms of Drug Interactions
Characteristics of Drug Interactions
Assessing the Clinical Impact of Drug Interactions
Chapter 5: Impact of Age on Pharmacology
Neonates, Infants, and Children
Summary and Clinical Context
Chapter 6: Pharmacogenetics
The Promise of Personalized Medicine
Pharmacogenetics and Pharmacogenomics
The Next Step: from Genetics to Genomics
Limitations of Pharmacogenomics
Resources for Pharmacogenetic Information
General Strategies for Management of Toxic Events
Pharmacologic Treatment of Specific Intoxications
Chapter 8: Herbal Medications
Reliability of Herbal Products
Efficacy of Herbal Medications
Specific Herbal Medications
Chapter 9: Drug Discovery and Evaluation
Chapter 10: Addiction and Abuse
Scope of the Substance Abuse Problem
Neurophysiology of Addiction
Central Nervous System Stimulants
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
Angiotensin Receptor Blockers (ARBs)
Sodium Channel Blockers (Class I Antiarrhythmics)
β Antagonists (β-Blockers)
Potassium Channel Blockers (Class III Antiarrhythmics)
Inhibitors of Cholesterol Synthesis: Statins
Phosphodiesterase-3 Inhibitors
Chapter 12: Cough, Cold, and Allergy
Chapter 14: Endocrinology
a-Glucosidase Inhibitors (AGIs)
Estrogen Receptor Antagonists
Aromatase Inhibitors (AIs)
Reproductive Prostaglandins (PGs)
Nonsteroidal Androgen Antagonists (NSAAs)
Growth Hormone Antagonists
Adrenocorticotropic Hormone (ACTH)
Chapter 15: Gastroenterology
Proton Pump Inhibitors (PPIs)
Direct Factor Xa Inhibitors
Direct Thrombin Inhibitors
Adenosine Diphosphate (ADP) Blockers
Antiplatelet IIb/IIIa Inhibitors
Colony-Stimulating Factors
Chapter 17: Immune Modifiers
Introduction to Monoclonal Antibodies
Tumor Necrosis Factor (TNF)–α Inhibitors
Target of Rapamycin (mTOR) Inhibitors
Chapter 18: Infectious Diseases
Introduction to Antibiotics
Sulfonamides and Other Folate Synthesis Inhibitors
Introduction to Antimycobacterials
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Nonnucleoside Reverse Transcriptase Inhibitors (nNRTIs)
Chapter 19: Musculoskeletal System
Nonsteroidal Antiinflammatory Drugs (NSAIDs)
Xanthine Oxidase Inhibitors
Gonadotropin-Releasing Hormone (GnRH) Analogues
Tyrosine Kinase Inhibitors
Chapter 21: Neurology and the Neuromuscular System
Nondepolarizing Neuromuscular Blockers
Depolarizing Neuromuscular Blockers
Dopamine and Dopamine Agonists
Catechol-O-Methyl Transferase (COMT) Inhibitors
Cholinesterase Inhibitors
γ-Aminobutyric acid (GABA) Analogues
Chapter 22: Ophthalmology
Ophthalmic Prostaglandins
Selective Serotonin Reuptake Inhibitors (SSRIs)
Tricyclic Antidepressants (TCAs)
Serotonin Noradrenaline Reuptake Inhibitors (SNRIs)
Noradrenergic and Specific Serotonergic Antidepressants (NaSSAs)
Monoamine Oxidase Inhibitors (MAOIs)
Noradrenaline and Dopamine Reuptake Inhibitors (NDRIs)
First-Generation Antipsychotics
Second-Generation Antipsychotics
Central Nervous System Stimulants
Chapter 24: Pulmonary System
Beta 2 (β2) Agonists (Bronchodilators)
Leukotriene Receptor Antagonists
Phosphodiesterase-5 Inhibitors
Endothelin Receptor Antagonists
Chapter 25: Renal and Genitourinary Systems
Potassium-Sparing Diuretics
Carbonic Anhydrase Inhibitors (CAIs)
Antidiuretic Hormone (Vasopressin) Analogues
Anticholinergics: Bladder
Applied Pharmacology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
